Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling. [electronic resource]
Producer: 20210107Description: e22480 p. digitalISSN:- 1099-0461
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm -- drug effects
- Ginsenosides -- pharmacology
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- PTEN Phosphohydrolase -- metabolism
- Pancreatic Neoplasms -- drug therapy
- Signal Transduction -- drug effects
- Transfection
- Tumor Burden -- drug effects
- Tumor Suppressor Proteins -- genetics
- Up-Regulation -- drug effects
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.